Hercessi
Payments companies reported to CMS as associated with Hercessi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hercessi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hercessi
These are the largest totals companies reported as associated with Hercessi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexandra Thomas | Winston Salem, NC | Hematology & Oncology | $4,350.00 |
| Mark Marinella | Kettering, OH | Medical Oncology | $33.88 |
| Gregory Rasp | Englewood, OH | Radiation Oncology | $33.87 |
| Mark Romer | Dayton, OH | Hematology & Oncology | $33.87 |
| Ruemu Birhiray | Indianapolis, IN | Hematology & Oncology | $28.25 |
| Mohammad Mobayed | Rochester Hills, MI | Hematology & Oncology | $25.08 |
| Martin Tapia | Royal Oak, MI | Hematology & Oncology | $25.06 |
| Li Ge | Fresno, CA | Medical Oncology | $24.95 |
| Jeanette Dressel | Spokane, WA | Nurse Practitioner | $24.94 |
| Naixi Chen | Renton, WA | Hematology & Oncology | $24.94 |
Prescribed Hercessi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.